Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

NCT07011589 is registered in ClinicalTrials.gov with M. Peter Marinkovich as lead sponsor.

NCT NCT07011589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07011589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
Lead sponsor
M. Peter Marinkovich
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
January 31, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophic epidermolysis bullosa, epidermolysis bullosa (eb), epidermolysis bullosa acquisita, recessive dystrophic epidermolysis bullosa